ABU DABİ 6 APRIL 2020 WAM
A team of cancer treatment specialists from around the world, coronavirus (COVID-19) has published the first international medical recommendations for the treatment of cancer patients during the outbreak.
These recommendations are based on a study called “An Applied Approach to the Management of Cancer Patients During the New Coronavirus Disease 2019 Outbreak”.
Funded by the Khalifa bin Zayed Al Nahyan Foundation and Roche, the study was led by Emirate physician Humaid Al-Shamsi, Advisor to Oncology and Cancer Diseases, Associate Professor of the University of Sharika and President of the Emirates Cancer Society.
Mohammed Haji Al Khouri, General Manager of Khalifa bin Zayed Al Nahyan Foundation, stated that the Foundation supports worldwide scientific research to protect human health regardless of religion, race, color, gender or language, stemming from the tolerance and approach to humanity reflected by the international human attitudes taken by the UAE’s leadership. .
Stressing that supporting scientific research is one of the Foundation’s priorities, especially during the current crisis, Al Khouri noted that international cooperation between the international group of experts under the supervision of the Emirates Cancer Foundation is a global success for the UAE.
Al Khouri, Dr. Al Shamsi and the science team who prepared the study expressed his hope that he will give hope to many cancer patients from all over the world during the current crisis.
“We have seen the dangers faced by cancer patients around the world during the current coronavirus outbreak and there is no international recommendation to treat them during the crisis. Therefore, we bring together international experts to make recommendations as soon as possible to create a global reference for all cancer therapists. Therefore, we collaborated with the Khalifa bin Zayed Al Nahyan Foundation and Swiss company Roche, a pioneer in the field of health and oncology technology, to collect data from Hubei in Italy, Taiwan, Singapore, the USA, Canada and Kuwait, China. ”
“The study was supervised by the Emirates Cancer Foundation under the roof of the Emirates Medical Association (EMA). We worked 24 hours a day for three weeks and made recommendations for coping with cancer patients during the coronavirus pandemic for the first time in the world.”
“This constructive work, which aims to help cancer patients all over the world, reflects the UAE’s tolerance and approach to helping others under all circumstances.” said.
The study was published in the latest edition of “The Oncologist”, a medical journal dedicated to the best care practices for cancer patients.
The study concluded that the risk and benefit assessment should be individualized for active intervention in the cancer population during an infectious disease epidemic, and the delay in elective surgery or chemotherapy for cancer patients with a low risk of progression should be assessed on a case-by-case basis.
He also proposed visits to outpatient patients and minimization of selective admissions to help reduce exposure and further transmission of COVID-19.
Roche, a world leader in healthcare, said this unique collaboration has brought together leading experts from around the world to treat cancer. The company has renewed its commitment to support any scientific research and praised the commitment made by researchers, doctors, and international pharmaceutical companies to prevent COVID-19.
President of the Emirates Medical Association. Mouza Abdullah Al Sharhan said that this breakthrough reflects the support of the Association for all efforts in the medical and scientific fields.
It praised the Emirates Oncology Association’s role in collaborating with leading research institutes to publish and implement the latest research findings in the UAE.
Professor Conghua Xie, Zhongnan Hospital of China Wuhan University Wuhan Radiation Oncology Department, however, said that despite the negative connotations of being the first city to coronavirus outbreak in the world, the crisis provided doctors there a great experience to deal with such cases.
“Such research papers inform doctors and specialists and help them cope with this virus. This initiative shows UAE’s interest in contributing to overcoming this epidemic.” said.
Professor of Critical Care, McMaster University School of Medicine, Canada. Waleed Alhazzani said the study recommendations have been carefully reviewed to ensure worldwide accuracy and as a reference to cancer therapists.
Clinician-Scientist Professor Melvin L.K. Chua said that this collaboration emphasizes the medical research specialists’ desire to help them make the right decisions for cancer patients during these difficult times.
GI Medical Oncology Professor of Medicine at MD Anderson Cancer Center in Houston, USA. Robert Wolff said the study is expected to increase awareness among cancer therapists around the world about making the right decision when treating cancer patients.
Dr. Milan University Medical Oncology Associate Professor. Giuseppe Curigliano said Italy’s painful experience motivated him to be part of the research to transfer knowledge and expertise to the world.
Dr. Professor of Hematology and Oncology at the Anderson Cancer Center. Nuhad Ibrahim said the UAE has always been at the forefront to support medical and scientific research.
Professor of Medicine (Hematology and Oncology) at the Vanderbilt Ingram Cancer Center of the United States. Cathy Eng said that this is the first global collaboration of its kind, and she hopes that further cooperation in research on cancer and COVID-19 will come soon.
Dr. Professor of Hematology and Oncology at the Anderson Cancer Center. Nuhad Ibrahim said the UAE has always been at the forefront to support medical and scientific research.
Professor of Medicine (Hematology and Oncology) at the Vanderbilt Ingram Cancer Center of the United States. Cathy Eng said that this is the first global collaboration of its kind, and she hopes that further cooperation in research on cancer and COVID-19 will come soon.
Canadian Juravinski Cancer Center Assistant Professor, Medical Oncologist Brandon M. Meyers thanked the UAE for its vital role in supporting medical and scientific research.
Medical oncologist and Gastrointestinal Cancer Research Director, USA, Western Cancer Center and Research Institute. Axel Grothey said that this unique initiative opened the door to future research cooperation.
Canada, Ontario, Professor of Western University. Tarek Elfiki described the work as a fruit of cooperation between a group of top experts and practitioners from around the world. He thanked the UAE for supporting this important research work.
Professor of Hematology, Blood and Marro Transplant at the Kuwait Cancer Control Center. Ahmad Alhuraiji said he is pleased to be a part of such international cooperation. He praised the team’s hard work, stating that the study findings, which usually take months to prepare, were prepared in less than three weeks.
Dr. Min-Sheng General Hospital, Taiwan, Department of Surgery. Meshari Almuhanna said the study findings and recommendations were the result of first-hand experience with cancer patients exposed to COVID-19.
“The proposals of the study form a core of the experiences that different team members experience in the hope that they will be useful in improving the conditions of cancer patients around the world.” said.
Dr. Princess Margaret Hospital, Toronto, Canada. Eric A. Coomes said that it is important for all experts to develop the right recommendations for cancer patients right now.
Professor of Oncology at the Juravinski Cancer Center in Canada. Sebastien J. Hotte provided rich information on how this co-operation will deal with coronavirus-infected cancer patients, including countries severely affected by COVID-19, such as China, Italy and Taiwan.
“It was very difficult to transfer this information to the world because of the current pressure of all doctors around the world. This study would not be developed (by the UAE) without support for scientific research.” said.
Translator: Esmeralda Angun.
http://wam.ae/en/details/1395302835221
